Home
About
Overview
Sharing Data
ORCID
Help
History (2)
EphB4 as a therapeutic target in mesothelioma.
Interleukin-12 Receptor beta 1 Subunit
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EphB4 as a therapeutic target in mesothelioma.
EphB4 as a therapeutic target in mesothelioma. BMC Cancer. 2013 May 30; 13:269.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Cell Line, Tumor
Drug Delivery Systems
Fluorescent Antibody Technique
Humans
Immunohistochemistry
In Situ Nick-End Labeling
Male
Mesothelioma
Mice
Mice, Inbred BALB C
Pleural Neoplasms
Receptor, EphB4
Serum Albumin
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia